Sony and Olympus formally enter the medical device market

Medical electronic channel news Japanese media reported on the 16th, Sony announced on the 16th, through the establishment of a medical device manufacturing and sales company with Olympus joint venture to formally enter the medical device market. In recent years, Sony TV and other home appliance businesses have suffered losses, and there is a lot of room for growth in the medical field. Sony aims to consolidate its revenue by strengthening its medical business. It is understood that the cooperation company established by Sony and Olympus is called "Sony Olympus Medical Solutions", and the headquarters is located in Hachioji City, Tokyo, where the Olympus Medical Research Center is located. The investment ratio of the two companies is 51% for Sony, Olympus 49. %.

Sony said that it will combine its own 3D image processing technology with Olympus' endoscopic technology to develop medical devices such as the most advanced surgical endoscopes.

There are predictions that the future scope of surgical endoscopes will be further expanded. It is estimated that the global market size in 2020 will reach 330 billion yen (about RMB 21.1 billion), 1.5 times the current level. Sony strives to seize 20% of the world. More than % market share.

Fluorescence Immunochromatography Instrument

Fluorescent Immunochromatographic Strip ,Trends In Fluorescence Immunochromatography,Labsim Fluorescent Immunoanalyzer Afs-1000,Principle Of Fluorescence Immunochromatography

Guangdong Hecin Scientific, Inc. , https://www.hecinscientific.com